Skip to main content
. Author manuscript; available in PMC: 2021 Jun 3.
Published in final edited form as: Small. 2021 Mar 18;17(18):e2007705. doi: 10.1002/smll.202007705

Figure 7.

Figure 7.

Representative qualitative clonogenic cell survival assay in murine YUMM1.G1 and human A375 melanoma cells regrown after treatments in fresh medium (1), PLL-CNC NPs (2), free vemurafenib (3), free 177Lu (4), [177Lu]Lu-CNC NPs (5), and [177Lu]Lu-CNC-V NPs (6) at doses of 1 MBq/mL for 177Lu, 40 μg/mL for CNC NPs, and 0.1 μM for vemurafenib at 6, 24, and 48 h.